COMBINEDBrain (@combined_brain) header
COMBINEDBrain (@combined_brain) profile picture

Consortium for Biomarkers and Outcome Measures for Neurodevelopmental Disorders https://nitter.cf/t.co/4odslIFF84

Nashville, TN
Joined August 2019
Photo by COMBINEDBrain (@combined_brain)Photo by COMBINEDBrain (@combined_brain)Photo by COMBINEDBrain (@combined_brain)Photo by COMBINEDBrain (@combined_brain)Photo by COMBINEDBrain (@combined_brain)Photo by COMBINEDBrain (@combined_brain)
You'll know by now that we've officially launched #60SecondsofRARE. To get involved, email rpender@rarerevolutionmagazine, and you'll receive four questions, including video guidelines Then, film yourself answering the four questions, and that's it!
2
1
6
722
#ShineYourSearchlight✨ Do you live in the USA? Make sure your genetic variant is part of the @SimonsSearchlight biorepository! Your blood sample can help in creating future therapies and treatments. Contact [email protected] to learn more. #OCNDS #CSNK2A1
1
5
349
COMBINEDBrain retweeted
Want to learn how to get involved on a state level? Join @EveryLifeOrg for their Apr. 12 webinar on Building Relationships with State Decision Makers. Learn best practices and hear directly from advocates who are taking action in their states. go.globalgenes.org/everylife…
10
13
1,341
NORD's #LivingRareForum is just one month away on Saturday, May 6, 2023! Join hundreds of patients, families, & #RareDisease community members in Washington, DC for a day full of education, inspiration, & celebration of NORD's 40th anniversary. Register: bit.ly/3Lu3oOZ
2
5
1
17
1,739
COMBINEDBrain retweeted
There are four active clinical trials for Angelman syndrome! New site locations have recently been added to the ongoing studies, and additionally, a new observational study was just announced. 🔬 Check out more info about these clinical trials: buff.ly/3nCm8VB
1
7
397
ASXL1 Awareness Day is a big day for a little populations-- so far, just about 150-200 individuals are identified as having ASXL1, or Bohring-Opitz Syndrome. It's one of a trio: ASXL1, ASXL2 and ASXL3. 1/
1
2
274
Great news, & great exposure for Angelman.
📰 A new article in the Wall Street Journal profiles FAST and its innovative approach to make cutting-edge clinical treatments available to everyone who needs them. Read the article here: buff.ly/3KAwi2d
1
193
🧵
NHGRI’s Clinical Director @BenjaminSolomo2 first fell in love with genetics and genomics in the 7th grade. In medical school, he admired geneticists who were determined to help diagnose patients.
124
COMBINEDBrain retweeted
🏛️ This work falls within FAST’s Pillar 4 - Accelerating and Preparing for Clinical Trials in our Roadmap to a Cure 2.0, and is particularly exciting for our community right now, given the multiple ongoing and emerging clinical trials.
1
1
125
COMBINEDBrain retweeted
A new publication from Dr. Anne Anderson’s lab at Baylor College of Medicine evaluates EEG as a tool, or biomarker, to objectively measure therapeutic efficacy in Angelman syndrome. Read more about the publication's findings: buff.ly/3KaM6r6
1
1
4
299
Bohring-Opitz Syndrom is one of three ASXL conditions: ASXL1 ASXL2 and ASXL3 The features and abilities of people with Bohring-Opitz Syndrome varies greatly. We do not yet know why there is broad variation in features and abilities. 1/
1
1
230
Watch here to learn more about ASXL1 on Today is Bohring-Opitz Awareness Day. Watch here to learn more youtu.be/7ntCz0GuYXk
1
119
About 150-200 people diagnosed with Bohring-Opitz & it is classified as "ultra rare."
94
youtu.be/zQjNsXg7FwYICYMI, replay this webinar on our biobank & partnership with Syngap Research fund for SYNGAP1. Biorepositories--banks of samples--are a powerful tool for medical research.
1
2
158
The biorepository is going on a roadshow--more details to come.
1
79
COMBINEDBrain retweeted
The *first* global #census for #STXBP1 is published! 903 patients from 45 countries! We know there are more STX'ers out there. Check out the news article and be counted! stxbp1disorders.org/news/stx… #STXBP1GlobalConnect @stxbp1
12
3
30
3,023